ABSTRACT
From 1995 to 2006 we performed embolisation in 9 patients with bilateral kidney cancer. Embolization of kidney with smallest cancer was done at the first stage with subsequent embolisation of tumor in the contralateral kidney. Technically all procedures were successful and were performed without complications. Operative intervention on the contralateral kidney was undertaken 1-4 months after embolization in 8 patients. Five patients are alive for 5 and more years. Four patients died in 34-49 months after intervention. Selective embolization is a safe and effective modality which expands our abilities to treat patients with bilateral kidney cancer. Embolization can be used as single treatment modality and in combination with subsequent surgery.
Subject(s)
Embolization, Therapeutic , Kidney Neoplasms/therapy , Renal Artery , Adult , Aged , Aged, 80 and over , Angiography , Embolization, Therapeutic/methods , Female , Follow-Up Studies , Humans , Kidney Neoplasms/mortality , Male , Middle Aged , Retrospective Studies , Survival Analysis , Treatment OutcomeABSTRACT
Parallel study of PSA and needle biopsy were performed in 356 men, aged 42-92 years; prostate cancer was detected in 182 cases while no cancer--in 174. When PSA level ranged 4-20 ng/ml, at density of 0.1-0.3, its specificity was low and cancer detection was under 50%. There was a direct correlation between the PSA indices and cancer detection rate, and nearly 100% of tumors were detected at the values of 25-30 ng/ml and 0.5-0.9 respectively. PSA level and especially results of morphological examination by means of prostate needle biopsy (Gleason) offer possibility to visualize tumor size and its malignant potential.
